The price of GMRE is predicted to go up -1.47%, based on the high correlation periods with EQT. The similarity of these two price pattern on the periods is 91.72%.
GMRE
EQT
Down: -1.47%Similarity: 91.72%
GMRE Revenue Forecast
GMRE EPS Forecast
GMRE FAQs
What is bull’s view on GMRE?
GMRE stock is currently trading at $9.23, with analysts maintaining a Hold rating and an average price target of $10.00. Bulls view GMRE as undervalued, citing its forward P/E ratio of 10.80 and a PEG ratio of 1.35, which indicate strong value metrics compared to peers. Additionally, its focus on healthcare facilities provides stability, making it attractive for long-term investors seeking consistent returns.
What is bear's view on GMRE?
GMRE stock closed at $7.84 on January 31, 2025, down 0.88% for the day. Bears argue that refinancing headwinds and underperformance compared to peers, with a one-year low of $7.98, indicate limited upside. Additionally, the stock's Hold ratings and a modest price target of $10 suggest weak near-term growth potential.
What is GMRE revenue forecast for next quarter?
The market consensus for GMRE's revenue in the upcoming quarter is projected to be approximately $35.407M USD.
Berenberg analyst Kai Klose initiated coverage of Global Medical REIT with a Buy rating and $11.75 price target. Healthcare real estate investment trusts in the U.S. were heavily affected by COVID-19, as capital markets took a more cautious view on the sector due to concerns about the solvency of operators, the analyst tells investors in a research note. However, with interest rates likely to take a downward trajectory, the share prices of healthcare REITs have already started to stabilize, contends the Berenberg. As a results, it expects the capital markets will view the supportive market fundamentals for Omega Healthcare Investors and Global Medical REIT more positively given the demographic development of the companies.